Anika Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $17.5M | $240.2M | $104.3M |
| FY2017 | $19.1M | $282.6M | $133.3M |
| FY2018 | $15.4M | $279.0M | $89.0M |
| FY2019 | $42.3M | $330.7M | $157.5M |
| FY2020 | $93.2M | $365.6M | $95.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $17.5M | $240.2M | $104.3M |
| FY2017 | $19.1M | $282.6M | $133.3M |
| FY2018 | $15.4M | $279.0M | $89.0M |
| FY2019 | $42.3M | $330.7M | $157.5M |
| FY2020 | $93.2M | $365.6M | $95.8M |